1.
Starczewski Łukasz, Osiński D, Kawa Z, Kasprzak M, Jędrzejewska A, Jureczko A, et al. Clinical Efficacy, Mechanism of Action, and Adverse Effects of SGLT2 Inhibitors and GLP-1 Receptor Agonists in the Treatment of Type 2 Diabetes – a Systematic Review. Qual Sport [Internet]. 2026 Apr. 16 [cited 2026 Apr. 21];54. Available from: https://apcz.umk.pl/QS/article/view/70481